UK public misunderstands cost and value of medicines, ABPI study finds

A new survey commissioned by the Association of the British Pharmaceutical Industry (ABPI) has revealed that the British public misunderstands the cost and value of medicines in the UK. The figures show that many mistakenly believe the National Health Service spends much more on medicines than it actually does, whilst there is poor understanding of the huge expense involved in their discovery, development, approval and launch.

The head of the ABPI believes it is vital that the public better understands the facts and fully appreciates their low cost compared to their considerable economic and health benefits.